Nurse Practitioner
Audio Summaries

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis

The authors aimed to evaluate the efficacy and safety of a 6-month treatment regimen for pulmonary rifampicin-resistant tuberculosis compared to the standard 9-month treatment in South Africa. The study found that the 6-month regimen was noninferior in achieving successful treatment outcomes and had a similar safety profile to the standard regimen. This suggests that the shorter treatment duration may be a viable alternative for managing rifampicin-resistant tuberculosis.

Neurocognitive Development in Adolescent Offspring at Familial High Risk of Schizophrenia or Bipolar Disorder and a Population-Based Control Group

The authors aimed to investigate neurocognitive development in adolescents at familial high risk for schizophrenia (FHR-SZ) and bipolar disorder (FHR-BP) compared to a population-based control group (PBC) at ages 7, 11, and 15. They found that offspring at FHR-SZ exhibited significant developmental delays in processing speed and deficits across various cognitive domains by age 15, while those at FHR-BP showed mostly normative development with minor deficits in semantic verbal fluency. These findings suggest that distinct neurocognitive trajectories could serve as potential predictors for the onset of schizophrenia or bipolar disorder.

Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

The authors aimed to evaluate the long-term outcomes of anti-CD19 CAR T-cell therapy (tisagenlecleucel) in patients with relapsed or refractory B-cell non-Hodgkin lymphomas over a median follow-up of 10.1 years. They found that approximately 32% of patients with large B-cell lymphoma and 47% with follicular lymphoma achieved lymphoma-free survival, with a notable persistence of B-cell aplasia in long-term responders. The study highlights the potential for durable remissions in this patient population, despite some risks of non-relapse-related mortality and secondary cancers.

Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial

The authors aimed to evaluate the efficacy of the Circadian Rhythm for Mood (CRM) smartphone app in preventing mood episode recurrence in patients with major depressive disorder (MDD) and bipolar disorder (BD). In a randomized clinical trial involving 93 adults, the CRM app significantly reduced the recurrence rate of mood episodes compared to a sham app, suggesting its potential as a digital adjunct to standard care for mood disorders.

Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples

This study investigates how various copy number variants (CNVs) associated with schizophrenia spectrum disorders (SSDs) influence severe phenotypes, specifically childhood-onset psychosis and borderline intellectual functioning (IQ). The authors found that known risk CNVs and deletions of genes involved in fetal brain development are significantly linked to poor cognitive outcomes in SSDs, suggesting that disrupted neurodevelopment plays a critical role in the clinical variability of these disorders. Additionally, the research highlights the potential of using a neurodevelopmental framework to better understand the mechanisms underlying severe SSD-related phenotypes.

Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals

The authors investigate the ethical implications of "slow codes" in U.S. hospitals, where clinicians perform resuscitation efforts without full commitment, often in response to patient or family requests despite the futility of such interventions. Their systematic review of 34 studies reveals a significant divide among physicians regarding the permissibility of slow codes, with most ethics literature deeming them impermissible due to concerns about deception, patient autonomy, and moral distress. The findings underscore the need for improved communication and ethical guidance in navigating end-of-life care decisions.

Deadly Heat: The Association Between Ambient Temperature and Suicide in Young People in the United States

The authors investigate the relationship between ambient temperature and suicide rates among young people (ages 5-24) in the United States, particularly focusing on seasonal variations. Their findings reveal that suicide rates increase significantly with rising temperatures, especially during summer months, with the most pronounced effect observed in individuals aged 15-24. This study underscores the need for further research on the mental health impacts of heat on youth and the development of targeted interventions.

Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial

The authors aimed to compare the effectiveness of self-directed cognitive behavioral therapy for chronic pain (CBT-CP) with asynchronous feedback to clinician-delivered CBT-CP in patients with chronic musculoskeletal pain. The study found that self-directed CBT-CP significantly reduced pain interference and improved secondary outcomes at 4 months, with benefits sustained at 12 months, suggesting it may be a more accessible alternative to traditional clinician-delivered therapy.

A Pragmatic SMART Study of Medication and CBT Sequencing in Pediatric Anxiety Disorders: A Randomized Clinical Trial

The authors aimed to determine whether starting treatment for pediatric anxiety disorders with fluoxetine or cognitive-behavioral therapy (CBT) leads to better outcomes, and how to optimize treatment if initial care is insufficient. The study found that symptom reduction was similar across all treatment sequences, with no significant advantage of combination therapy over monotherapy after three months. Additionally, the effectiveness of treatment varied by racial and ethnic background, suggesting the importance of tailoring approaches to individual patient preferences.

Prevention and Treatment of Peanut Allergy

This paper investigates the effectiveness of early peanut protein introduction and immunotherapy in preventing and treating peanut allergy. The authors find that introducing peanut protein early significantly reduces allergy prevalence, with optimal prevention strategies differing for low and high-risk infants. Additionally, they highlight that immunotherapy is more effective when started in younger children, emphasizing the critical need for early intervention.